Biotech company Sensorion has announced the appointment of David Lawrence as CFO, effective March 1. He was previously CFO of Valneva, where he sat on the Board of Directors.

David Lawrence was then responsible for investor relations and communications, as well as overseeing the vaccine company's financial management.

During his tenure at Valneva, he was instrumental in several financings, including an IPO on Nasdaq, and by the time he left the company, its market capitalization had reached over two billion euros', Sensorion points out.

Copyright (c) 2023 CercleFinance.com. All rights reserved.